19:51 , Jul 28, 2017 |  BC Week In Review  |  Company News

Feinstein grants Applied Immunotherapeutics rights to HMGB1 candidates

The Feinstein Institute for Medical Research (Manhasset, N.Y.) granted Applied Immunotherapeutics Inc. (Morris, Conn.) exclusive, worldwide rights to three preclinical candidates. Applied Immunotherapeutics gained rights to 2G7, a mAb against high mobility group box 1...